| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cdaae0f5fdf5bc144ffd8c372f864c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5728 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16 |
| filingDate |
2018-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2bf6bf0f05f0e001b244b127cf10335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdd640684384c1ec20984a80f99c365e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e668b3d4b134c69ad670bca4c56bf6e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14361cdcbcb85a711383f211982e2515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a2bb89943eec08c80b57a5f28228054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04a1231e453a224ab008ffb9c0608e51 |
| publicationDate |
2020-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3694835-A1 |
| titleOfInvention |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| abstract |
The present invention relates to the large scale production of psilocybin for use in medicine. More particularly, the invention relates to a process for obtaining crystalline psilocybin of high purity, in particular in the form of a polymorph A. The invention further relates to a process for producing psilocybin and intermediates involved in their production. production as well as formulations containing psilocybin. |
| priorityDate |
2017-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |